Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 26, 2022

Drug Price Trends for NDC 00093-9224

✉ Email this page to a colleague

« Back to Dashboard

Average Pharmacy Cost for 00093-9224

Subscribe to access the full database, or Sign up for a Free Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
MESALAMINE ER 0.375 GRAM CAP	00093-9224-89	2.06274	EACH	2021-06-23
MESALAMINE ER 0.375 GRAM CAP	00093-9224-89	2.19575	EACH	2021-05-19
MESALAMINE ER 0.375 GRAM CAP	00093-9224-89	2.26197	EACH	2021-04-21
MESALAMINE ER 0.375 GRAM CAP	00093-9224-89	2.22235	EACH	2021-03-17
MESALAMINE ER 0.375 GRAM CAP	00093-9224-89	2.33275	EACH	2021-02-17
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Best Wholesale Price for NDC 00093-9224

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Subscribe to access the full database, or Sign up for a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
MESALAMINE 375MG CAP,SA	Teva Pharmaceuticals USA, Inc.	00093-9224-89	120	145.86	1.21550	2022-01-01 - 2022-08-22	FSS
MESALAMINE 375MG CAP,SA	Teva Pharmaceuticals USA, Inc.	00093-9224-89	120	145.86	1.21550	2021-08-23 - 2022-08-22	FSS
MESALAMINE 375MG CAP,SA	Teva Pharmaceuticals USA, Inc.	00093-9224-89	120	145.86	1.21550	2021-04-15 - 2022-08-14	Big4
MESALAMINE 375MG CAP,SA	Teva Pharmaceuticals USA, Inc.	00093-9224-89	120	145.86	1.21550	2021-04-15 - 2022-08-14	FSS
MESALAMINE 375MG CAP,SA	Teva Pharmaceuticals USA, Inc.	00093-9224-89	120	142.07	1.18392	2021-08-23 - 2022-08-14	Big4
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Medtronic

Express Scripts

AstraZeneca

Harvard Business School

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.